参考文献/References:
[1] Schillinger M, Exner M, Mlekusch W, et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis[J]. Radiology, 2002, 225: 21 26.
[2] J?覿msén T, Manninen H, Tulla H, et al. The final outcome of primary infrainguinal percutaneous transluminal angioplasty in 100 consecutive patients with chronic critical limb ischemia[J]. J Vasc Interv Radiol, 2002, 13: 455 463.
[3] Wang J, Zhu YQ, Zhao JG, et al. Infrapopliteal angioplasty with a long over the wire (OTW) balloon in the treatment of severe limb ischemia in diabetic patients: a retrospective study[J]. Acta Radiol, 2009, 50: 360 367.
[4] Zhu YQ, Zhao JG, Liu F, et al. Subintimal angioplasty for below the ankle arterial occlusions in diabetic patients with chronic critical limb ischemia[J]. J Endovasc Ther, 2009, 16: 604 612.
[5] Mannava K, Money SR. Current management of peripheral arterial occlusive disease: a review of pharmacologic agents and other interventions[J]. Am J Cardiovasc Drugs, 2007, 7: 59 66.
[6] 王 燕, 段 峰, 李志伟, 等. 预防血管内支架植入术后再狭窄的研究进展[J]. 介入放射学杂志, 2011, 20: 665 668.
[7] Antithrombotic Trialists’ Collaboration. Collaborative meta analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients[J]. Br Med J 2002; 12; 324: 71–86.
[8] Alvarez Perez FJ, Castelo Branco M, Alvarez Sabin J. Usefulness of measurement of fibrinogen, D dimer, D dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke[J]. J Neurol Neurosurg Psychiatry, 2011, 82: 986 992.
[9] 韩 健, 郭富强. 经皮腔内血管成形术后再狭窄的炎症预测因子[J]. 介入放射学杂志, 2009, 18: 876 879.
[10] De Moerloose P, Boehlen F, Neerman Arbez M. Fibrinogen and the risk of thrombosis[J]. Semin Thromb Hemost, 2010, 36: 7 17.
[11] Schillinger M, Exner M, Mlekusch W, et al. Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries[J]. Thromb Haemost, 2002, 87: 959 965.
[12] Sacks D, Marinelli DL, Martin LG, et al. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices[J]. J Vasc Interv Radiol, 2003, 14: S395 S404.
[13] Germano G, Hobbs R, Hoes A, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)[J]. Eur Heart J, 2012; 33: 1635 1701.
[14] Ishii H, Kumada Y, Toriyama T, et al. Cilostazol improves long term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease[J]. Clin J Am Soc Nephrol, 2008, 3: 1034 1040.
[15] Serrano SM. The long road of research on snake venom serine proteinases[J]. Toxicon, 2013, 62: 19 26.
[16] Xu G, Liu X, Zhu W, et al. Feasibility of treating hyperfibrinogenemia with intermittently administered batroxobin in patients with ischemic stroke/transient ischemic attack for secondary prevention[J]. Blood Coagul Fibrinolysis, 2007, 18: 193 197.
[17] Wilensky RL, March KL, Gradus Pizlo I, et al. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit[J]. Circulation, 1995, 92: 2995 3005.
[18] 薛 波, 张培蕾, 王 珏, 等. 巴曲酶预防糖尿病膝下血管病变介入成形术后再狭窄的前瞻性随机对照研究[J]. 介入放射学杂志, 2011, 20: 202 206.
相似文献/References:
[1]张彩珍,田巧莲,苏秀琴,等.介入放射治疗中病人的护理[J].介入放射学杂志,1999,(02):54.
[2]金惠根,李京波,陆志刚,等.冠脉支架内血栓形成致急性心肌梗死[J].介入放射学杂志,2000,(01):27.
[3]金惠根,陆志刚,顾水明,等.直接冠脉内支架术治疗冠脉狭窄[J].介入放射学杂志,2000,(02):109.